|

9-valent HPV vaccine, 3 doses standard timing Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 4: 1

Top Sponsors

  • The University of Texas Medical Branch, Galveston1

Indications

  • Immunization1
  • Human Papillomavirus1
  • HPV Infection1
  • Cancer1

Galveston, Texas1 trial

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

University of Texas Medical Branch

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.